Sustained rheumatoid arthritis remission is uncommon in clinical practice

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Prince, Femke H M ^a   Bykerk, Vivian P ^a   Shadick, Nancy A ^a   Lu, Bing ^a   Cui, Jing ^a   Frits, Michelle ^a   Iannaccone, Christine K ^a   Weinblatt, Michael E ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMERICAN COLLEGE OF RHEUMATOLOGY; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ACTIVITY SCORE 28 C REACTIVE PROTEIN; DISEASE DURATION; EUROPEAN LEAGUE AGAINST RHEUMATISM; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SIMPLIFIED DISEASE ACTIVITY INDEX; SURVIVAL TIME; COHORT ANALYSIS; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TIME;

ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; TIME FACTORS;

EID: 84858328629     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3785     Document Type: Article

References (32)

1. Sokka T. Long-term outcomes of rheumatoid arthritis. Current Opin Rheumatol 2009, 21:284-290.
2. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69:964-975. 10.1136/ard.2009.126532, 2935329, 20444750.
3. Bykerk VP. Rheumatoid arthritis: 2011 remission criteria are a new benchmark for RA therapy. Nat Rev Rheumatol 2011, 7:317-318. 10.1038/nrrheum.2011.63, 21556029.
4. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005, 7:R796-806. 10.1186/ar1740, 1175030, 15987481.
5. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981, 24:1308-1315. 10.1002/art.1780241012, 7306232.
6. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
7. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003, 42:244-257.
8. Felson DT, Smolen J, Wells G, Zhang B, Van Tuyl LH, Funovits J, Aletaha D, Allaart CF. Predictive validity of the new preliminary ACR/EULAR definitions for remission in rheumatoid arthritis. Arthritis Rheum 2010, 62(Suppl 10):2108.
9. Felson DT, Smolen JS, Wells G, Zhang B, Van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardier S. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials. Arthritis Rheum 2011, 63:573-586. 10.1002/art.30129, 3115717, 21294106.
10. O'Dell JR, Mikuls TR. To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis. Arthritis Rheum 2011, 63:587-589. 10.1002/art.30199, 21294107.
11. Jacobsson LT, Hetland ML. New remission criteria for RA: "modern times" in rheumatology: not a silent film, rather a 3D movie. Ann Rheum Dis 2011, 70:401-403. 10.1136/ard.2010.145607, 21292832.
12. Schoels M, Knevel R, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas DT, Burmester G, Combe B, Cutolo M, Dougados M, Emery P, van der Heijde D, Huizinga TW, Kalden J, Keystone EC, Kvien TK, Martin-Mola E, Montecucco C, de Wit M, Smolen JS. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 2010, 69:638-643. 10.1136/ard.2009.123976, 3015093, 20237123.
13. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, . T2T Expert Committee Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010, 69:631-637. 10.1136/ard.2009.123919, 3015099, 20215140, T2T Expert Committee.
14. Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, Solomon DH, Weinblatt ME, Shadick NA. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford) 2011, 50:40-46.
15. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis 2007, 66:407-409. 10.1136/ard.2006.054205, 1856019, 16926186.
16. Castrejon I, Ortiz AM, Toledano E, Castaneda S, Garcia-Vadillo A, Patino E, Gonzalez-Alvaro I. Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis. J Rheumatol 2010, 37:1439-1443. 10.3899/jrheum.091333, 20472931.
17. Verschueren P, Esselens G, Westhovens R. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Scand J Rheumatol 2009, 38:166-172. 10.1080/03009740802484846, 19169906.
18. Balsa A, Del Amo J, Blanco F, Caliz R, Silva L, Sanmarti R, Martinez FG, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Collado MD, Andreu JL, Graell E, Simón L, Martínez A, Mulero J. Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. Rheumatology (Oxford) 2010, 49:458-466.
19. Schipper LG, Fransen J, den Broeder AA, Van Riel PL. Time to achieve remission determines time to be in remission. Arthritis Res Ther 2010, 12:R97. 10.1186/ar3027, 2911884, 20487520.
20. Miriovsky BJ, Michaud K, Thiele GM, O'Dell JR, Cannon GW, Kerr G, Richards JS, Johnson D, Caplan L, Reimold A, Hooker R, Mikuls TR. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis 2010, 69:1292-1297. 10.1136/ard.2009.122739, 3122886, 20439294.
21. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger PA. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001, 27:85-95.
22. Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS. Assessing remission in clinical practice. Rheumatology (Oxford) 2007, 46:975-979.
23. Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimić A, Nedović J, Stanković A, Bergman M, Toloza S, Pincus T, . Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008, 58:2642-2651. 10.1002/art.23794, 18759292, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group.
24. Sokka T, Makinen H, Hannonen P, Pincus T. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford) 2007, 46:1020-1023.
25. Verstappen SM, van Albada-Kuipers GA, Bijlsma JW, Blaauw AA, Schenk Y, Haanen HC, Jacobs JW. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Ann Rheum Dis 2005, 64:38-43. 10.1136/ard.2003.014928, 1755186, 15130899.
26. van der Heijde D, Klareskog L, Boers M, Landewe R, Codreanu C, Bolosiu HD, Pedersen R, Fatenejad S. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis 2005, 64:1582-1587. 10.1136/ard.2004.034371, 1755254, 15860509.
27. Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F. Remission of rheumatoid arthritis in clinical practice: application of the ACR/EULAR 2011 remission criteria. Arthritis Rheum 2011, 63:3204-3215. 10.1002/art.30524, 21739423.
28. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004, 50:36-42. 10.1002/art.11481, 14730597.
29. Molenaar ET, Lems WF, Dijkmans BA, de Koning MH, van de Stadt RJ, Voskuyl AE. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford) 2000, 39:742-744.
30. Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 2011,
31. Isaacs JD. The changing face of rheumatoid arthritis: sustained remission for all?. Nat Rev Immunol 2010, 10:605-611. 10.1038/nri2804, 20651747.
32. Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M, Rossi F, Sala I, Martini A, Ravelli A. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol 2009, 36:628-634. 10.3899/jrheum.080560, 19208600.